Greenlight's David Einhorn dumps most of Peloton stake, adds big industrial bet

David Einhorn's Greenlight Capital significantly divested from Peloton (PTON), reducing its stake by over 96% to just $1.2 million, despite the stock's recent 19% surge on surprising earnings, as it remains down 2% year-to-date. Concurrently, Greenlight established a new, substantial position in industrial firm Fluor (FLR), valued at nearly $200 million and becoming its second-largest holding, signaling a value-oriented shift given FLR's 15% year-to-date decline. This portfolio reallocation underscores Einhorn's strategic pivot towards perceived value opportunities and away from a prior high-profile, underperforming growth bet.

Analysis

David Einhorn's Greenlight Capital has executed a significant portfolio shift, liquidating over 96% of its stake in Peloton (PTON) just a year after initiating the position. This divestment to a nominal $1.2 million holding is particularly noteworthy as it comes on the heels of Peloton reporting a surprise quarterly profit and its stock surging 19% in the current month. Einhorn's exit, from a stock he once publicly championed as "significantly undervalued," suggests a fundamental loss of conviction in the company's turnaround, especially since the shares remain down 2% year-to-date, starkly underperforming the S&P 500. Concurrently, Greenlight has redeployed capital into a new, high-conviction value play, establishing a nearly $200 million position in industrial firm Fluor (FLR), making it the fund's second-largest holding. This investment aligns with Einhorn's value-oriented strategy, targeting a company whose stock has declined more than 15% this year. This strategic reallocation, coupled with smaller new stakes in Sotera Health, Cigna, and Victoria's Secret, signals a decisive pivot away from a speculative turnaround story towards beaten-down value assets, consistent with Einhorn's stated concerns about excessive market speculation.

Key Decisions for Investors

• Consider Einhorn's near-total exit from Peloton (PTON) as a significant red flag regarding its long-term turnaround, questioning the sustainability of the recent rally despite a positive earnings report.
• Investigate Fluor (FLR) as a potential deep-value, contrarian opportunity, given Greenlight's new, high-conviction stake worth nearly $200 million in the underperforming industrial name.
• Evaluate portfolio allocation in light of this strategic rotation from a high-profile growth story to an industrial value stock, which may signal a broader theme of seeking quality in undervalued sectors.
• Add the new, smaller positions in Sotera Health (SHC), Cigna (CI), and Victoria's Secret (VSCO) to a watchlist, as they may represent emerging value opportunities identified by a prominent manager.